MEDICINAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR

摘要

[Problem] To provide a medicinal composition for promoting the synthesis of vascular endothelial nitrogen oxide and/or maintaining or elevating the concentration of vascular endothelial nitrogen oxide in the blood, or a medicinal composition for improving blood lipids. [Means for Resolution] A medicinal composition which contains an HMG-CoA reductase inhibitor, gamma-oryzanol and/or thiamines.